Latest News by Industry
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Tuesday reported a loss of $182.2 million in its fourth quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $2.28.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share.
The vaccine maker posted revenue of $357.4 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $377.6 million.
For the year, the company reported that its loss narrowed to $657.9 million, or $8.42 per share. Revenue was reported as $1.98 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a NVAX">Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX